Targeted animal models for preclinical assessment of cellular and gene therapies in pancreatic and liver diseases: regulatory and practical insights.

Cellular and gene therapy (CGT) products have emerged as a popular approach in regenerative medicine, showing promise in treating various pancreatic and liver diseases in numerous clinical trials. Before these therapies can be tested in human clinical trials, it is essential to evaluate their safety and efficacy in relevant animal models. Such preclinical testing is often required to obtain regulatory approval for investigational new drugs.

The Impact of Early Diagenesis on Biosignature Preservation in Sulfate Evaporites: Insights From Messinian (Late Miocene) Gypsum.

Due to their fast precipitation rate, sulfate evaporites represent excellent repositories of past life on Earth and potentially on other solid planets. Nevertheless, the preservation potential of biogenic remains can be compromised by extremely fast early diagenetic processes. The upper Miocene, gypsum-bearing sedimentary successions of the Mediterranean region, that formed ca.

Micro- and Nanostructured Biomaterials for Biomedical Applications and Regenerative Medicine.

Over the past two decades, research on innovative micro- and nano-biomaterials has seen a significant surge in the bioengineering, biomedicine, and regenerative medicine fields [...

Human dental pulp stem cells modulate pro-inflammatory macrophages both through cell-to-cell contact and paracrine signaling.

Introduction: Macrophages play a key role in most of the inflammatory diseases such as Rheumatoid Arthritis (RA), but the mechanism underlying their pathogenesis is still under study. Among stem cells, human dental pulp stem cells (hDPSCs) have attracted attention due to their easy accessibility and immunomodulatory properties, making them a promising adjuvant therapy. In this study, we aimed to evaluate the capacity of hDPSCs to modulate the phenotypes of primary human macrophages.